HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $410,161 | +42.4% | 11,371 | +50.8% | 0.05% | +35.3% |
| Q1 2023 | $288,000 | -31.7% | 7,541 | +1.7% | 0.03% | -39.3% |
| Q4 2022 | $421,743 | +47.5% | 7,412 | +2.5% | 0.06% | +33.3% |
| Q3 2022 | $286,000 | -10.1% | 7,230 | 0.0% | 0.04% | -4.5% |
| Q2 2022 | $318,000 | +7.4% | 7,230 | -2.7% | 0.04% | +22.2% |
| Q1 2022 | $296,000 | +13.0% | 7,427 | +14.0% | 0.04% | +5.9% |
| Q4 2021 | $262,000 | -0.4% | 6,516 | +0.6% | 0.03% | -8.1% |
| Q3 2021 | $263,000 | -23.3% | 6,475 | -14.2% | 0.04% | -27.5% |
| Q2 2021 | $343,000 | +63.3% | 7,546 | +50.0% | 0.05% | -8.9% |
| Q1 2021 | $210,000 | +4.0% | 5,030 | +6.5% | 0.06% | +3.7% |
| Q4 2020 | $202,000 | – | 4,722 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |